Otsuka Holdings
4578.T
#748
Rank
ยฃ23.44 B
Marketcap
ยฃ44.38
Share price
0.47%
Change (1 day)
-1.71%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2023: ยฃ11.14 Billion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is ยฃ10.85 Billion. In 2023 the company made a revenue of ยฃ11.14 Billion an increase over the revenue in the year 2022 that were of ยฃ10.78 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2023

Annual revenue

Year Revenue Change
2023ยฃ11.14 B3.37%
2022ยฃ10.78 B8.94%
2021ยฃ9.89 B0.48%
2020ยฃ9.85 B0.85%
2019ยฃ9.76 B5.88%
2018ยฃ9.22 B12.85%
2017ยฃ8.17 B-7.96%
2016ยฃ8.88 B9.88%
2015ยฃ8.08 B
2013ยฃ8.56 B-3.21%
2012ยฃ8.85 B-3.75%
2011ยฃ9.19 B11.05%
2010ยฃ8.28 B